
Tirzepatide
Tirzepatide Weight Loss
As the ol' saying goes, "weight loss is a marathon, not a sprint."
It takes time and effort, with the focus being on losing fat rather than weight (which includes muscle mass).
Be patient with yourself, cultivate a positive mindset, and focus on creating sustainable, healthy habits!
We can help.
In a study of obese or overweight adults who did not have diabetes, participants taking Tirzepatide for 36 weeks lost an average of 20% of their body weight!
Tirzepatide Eligibility
Healthcare providers evaluate and identify people
most likely to benefit from Tirzepatide, including:
1. BMI/Obesity Status: Generally for adults with obesity (BMI of 30+) or those with overweight (BMI of 27+).
2. Presence of Type 2 Diabetes: It is not approved for those with Type 1 Diabetes.
3. Weight-Related Conditions: People without diabetes but with obesity-related risks (e.g. cardiovascular disease, sleep apnea, and more).
4. Prior Weight Management Efforts: Those who have tried other weight management options (e.g. diet, exercise, medications) without successful or sustainable results.
5. Medical History/Medications: Certain medications might interact with Tirzepatide or its effectiveness. Existing health issues, such as gastrointestinal problems or thyroid cancer history, may affect eligibility.
6. Commitment to Lifestyle Changes: Tirzepatide works best when combined with a healthy diet, an active lifestyle, and other modifications that support long-term weight management.
7. Ability to Manage Side Effects: Some may experience side effects, such as nausea or digestive issues.
8. Access to Follow-up Care
9. Age: Tirzepatide is approved for use in individuals 18 and over.
A thorough medical consultation is essential to ensure that
Tirzepatide is safe and appropriate for every candidate!
Studies have also indicated that Tirzepatide may offer health benefits beyond weight management, potentially improving blood pressure, reducing high cholesterol, and aiding blood sugar regulation. Guidance is essential to ensure successful integration into a comprehensive weight plan.
How Tirzepatide Works
When you eat, your digestive system releases two hormones:.
Tirzepatide mimics these hormones and activates their receptors. In turn, Tirzepatide increases insulin production after meals, slows digestion, and reduces hunger.
Unlike similar medications that only target one hormone, Tirzepatide combines effects from both hormones, making it an effective treatment for managing Type 2 diabetes and promoting weight loss in those who are obese or overweight.
What is Tirzepatide?
-
Created as part of an ongoing effort to develop more effective treatments for Type 2 diabetes and obesity.
-
Rooted in the research on how certain hormones regulate blood sugar, appetite, and weight.
-
Designed to target two important hormones in the body to help control blood sugar levels and promote weight loss.
-
Approved under the brand name Mounjaro in 2022 to improve glycemic control in adults with Type 2 Diabetes Mellitus.
-
Known under the name Zepbound for weight loss purposes.
Almost 90% of patients who stayed on Tirzepatide maintained their weight loss. A study released by the NIH found that once patients go off medications like Tirzepatide the average weight gain rebound is about two-thirds of the total weight loss during treatment.
Weight Loss Facts
-
The CDC reports that nearly 75% of Americans are obese and/or overweight.
-
Worldwide, adult obesity has more than doubled since 1990, and adolescent obesity has quadrupled.
-
Weight loss is a sustained effort; there is no quick fix or one-size-fits-all solution.
-
Losing weight does not mean going hungry!
-
You need sleep! Inadequate sleep increases stress, raising cortisol levels, and disrupts hormones such as leptin and ghrelin, which regulate hunger and satiety, leading to more cravings.
-
In 2024, it's estimated that 35 million children under the age of 5 were overweight.
-
According to the WBO, the global costs of overweight and obesity are expected to be about US$ 3 trillion per year by 2030 and over US$ 18 trillion by 2060.
-
Men generally lose weight faster since they carry more lean muscle.
-
Approximately 90% of people who lose a lot of weight eventually gain it back. (Again, it's a sustained effort!)
-
About 1/4 of Americans use a fitness tracker (24%) or a health app (26%) to monitor progress, per a 2024 Gallup Poll.
-
According to WHO, worldwide, the weight management market is projected to grow from $427.5 billion in 2025 to $896.5 billion by 2035.